Search Results

Showing 41 – 57 of 57 results

ARISe at UMass Chan

by CTG

in Vaccination, Vaccination Promotion

Other

Massachusetts

Deadline:

09/30/2026

Influenza Human Challenge Model

by CTG

in Influenza

Other

Georgia

Deadline:

12/01/2027

T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation

by CTG

in Viral Infections, Bone Marrow Transplant Infection

Other

District of Columbia

Deadline:

11/01/2026

Tfh Dysfunction in HIV and Aging

by CTG

in Human Influenza

Other

Florida

Deadline:

12/30/2026

Dime La VerDAD: Verify, Debunk, and Disseminate

by CTG

in Influenza, COVID-19, Communication Research, Vaccine Hesitancy, Misinformation

Other

Illinois

Deadline:

04/01/2028

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

by CTG

in Human Papillomavirus-Related Carcinoma, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Advanced Oropharyngeal Carcinoma, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Other

Minnesota

Deadline:

10/01/2026

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

by CTG

in CD30-Positive Diffuse Large B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, Anaplastic Large Cell Lymphoma, ALK-Positive, Peripheral T-cell Lymphoma, Anaplastic Large Cell Lymphoma, ALK-negative

Other

Texas

Deadline:

06/27/2043

Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection

by CTG

in Healthy Volunteers

Other

Mississippi

Deadline:

06/30/2026

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

by CTG

in Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Histiocytic and Dendritic Cell Neoplasm

Other

Arizona

Deadline:

04/01/2032

Study of Immune Responses to Influenza Vaccination

by CTG

in Influenza Vaccination

Other

Pennsylvania

Deadline:

07/01/2026

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

by CTG

in Spinal Cord Injuries, Healthy Controls, Traumatic Spinal Cord Injury, Flu Vaccine, COVID-19 Vaccine

Other

New York

Deadline:

12/31/2027

Bone Marrow and Peripheral Blood Immune Responses Study

by CTG

in Influenza

Other

Georgia

Deadline:

12/01/2029

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

by CTG

in High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma

Other

Colorado

Deadline:

06/15/2030

Inflammatory Challenge and Fear

by CTG

in Posttraumatic Stress Disorder (PTSD)

Other

California

Deadline:

11/01/2028

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

by CTG

in Vaccine Hesitancy, Vaccine Refusal

Other

Georgia

Deadline:

06/01/2026

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

by CTG

in Lung Cancer, Head and Neck Cancer, Gastrointestinal Cancer

Other

Maryland

Deadline:

08/25/2026

Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

by CTG

in Acute Otitis Media

Other

New York

Deadline:

12/31/2026

Your Selected

ARISe at UMass Chan

Influenza Human Challenge Model

T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation

Tfh Dysfunction in HIV and Aging

Dime La VerDAD: Verify, Debunk, and Disseminate

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Study of Immune Responses to Influenza Vaccination

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Bone Marrow and Peripheral Blood Immune Responses Study

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Inflammatory Challenge and Fear

Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps